Research progress on STAT3 and pathogenesis of Parkinson's disease

doi:10.16352/j.issn.1001-6325.2022.12.1935

Abstract

CLC Number:

WU Chang-bao, HAO Yan-lei. Research progress on STAT3 and pathogenesis of Parkinson's disease[J]. Basic & Clinical Medicine, 2022, 42(12): 1935-1938.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.12.1935

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I12/1935

[1]Tran KKN, Wong VHY, Lim JKH, et al. Characterization of retinal function and structure in the MPTP murine model of Parkinson's disease[J].Sci Rep, 2022,12:7610-7620.
[2]Dong J, Cheng XD, Zhang WD, et al. Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation[J].J Med Chem,2021,64:8884-8915.
[3]Qin J, Shen X, Zhang J, et al. Allosteric inhibitors of the STAT3 signaling pathway[J]. Eur J Med Chem, 2020,190:112-122.
[4]Shiah JV, Grandis JR, Johnson DE. Targeting STAT3 with proteolysis targeting chimeras and next-generation antisense oligonucleotides[J].Mol Cancer Ther, 2021,20:219-228.
[5]Liu L, Wang J, Wang H. Hydrogen sulfide alleviates oxidative stress injury and reduces apoptosis induced by MPP⁺ in Parkinson's disease cell model[J].Mol Cell Biochem, 2020,472:231-240.
[6]Xu Z,Yang D,Huang X, et al. Astragaloside Ⅳ protects 6-hydroxydopamine-induced SH-SY5Y cell model of Parkinson's disease via activating the JAK2/STAT3 pathway[J].Front Neurosci,2021,15:631501-631510.
[7]He D,Chen S,Xiao Z, et al. Bisdemethoxycurcumin exerts a cell-protective effect via JAK2/STAT3 signaling in a rotenone-induced Parkinson's disease model in vitro[J].Folia Histochem Cytobiol,2020,58:127-134.
[8]Wang Q, Liu Y. Cryptotanshinone ameliorates MPP⁺-induced oxidative stress and apoptosis of SH-SY5Y neuroblastoma cells: the role of STAT3 in Parkinson's disease[J]. Metab Brain Dis, 2022,37:1477-1485.
[9]Pajares MI, Rojo A, Manda G, et al. Inflammation in Parkinson's disease: mechanisms and therapeutic implications[J].Cells,2020,9:1687-1718.
[10]Wang X, Li X, Zuo X, et al. Photobiomodulation inhibits the activation of neurotoxic microglia and astrocytes by inhibiting Lcn2/JAK2-STAT3 crosstalk after spinal cord injury in male rats[J].J Neuroinflammation, 2021,18:256-275.
[11]Cong L, Lei MY, Liu ZQ, et al. Resveratrol attenuates manganese-induced oxidative stress and neuroinflammation through SIRT1 signaling in mice[J]. Food Chem Toxicol, 2021,153:112283-112295.
[12]Wang X,Liu Z,Wang F.MicroRNA-93 blocks signal transducers and activator of transcription 3 to reduce neuronal damage in Parkinson's dsease[J].Neurochem Res,2021,46:1859-1868.
[13]Hashioka S, McGeer EG, et al. Interferon-γ-induced neurotoxicity of human astrocytes[J]. CNS Neurol Disord Drug Targets,2015,14:251-256.
[14]Choi JY, Yun J, Hwang CJ, et al. (E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl) phenol ameliorates MPTP-induced dopaminergic neurodegeneration by inhibiting the STAT3 pathway[J].Int J Mol Sci,2019,20:2632-2647.
[15]Srinivasan E, Chandrasekhar G, Chandrasekar P, et al. Alpha-synuclein aggregation in Parkinson's disease[J].Front Med,2021:736978.
[16]Li Y, Xia Y, Yin S, et al. Targeting microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson's dsease[J].Front Immunol, 2021,12:719807-719822.
[17]Zhang J, Zhou DW, Zhang Z, et al.miR-let-7a suppres-ses α-Synuclein-induc-ed microglia inflammation through targeting STAT3 in Parkinson's disease[J].Biochem Biophys Res Commun,2019,519:740-746.
[18]Liu J, Shi M, Hong Z, et al. Identification of ciliary neurotrophic factor receptor alpha as a mediator of neurotoxi-city induced by alpha-synuclein[J]. Proteomics,2010,10:2138-2150.
[19]Iravanpour F, Dargahi L, Rezaei M, et al. Intranasal insulin improves mitochondrial function and attenuates motor deficits in a rat 6-OHDA model of Parkinson's disease[J].CNS Neurosci Ther, 2021,27:308-319.
[20]Zeng L, Li A, Zhang Z, et al. Ropivacaine induces cell cycle arrest in the G0/G1 Phase and apoptosis of PC12 cells via inhibiting mitochondrial STAT3 translocation[J].Inflammation,2021,44:2362-2376.
[21]Qian ZM, Ke Y. Hepcidin and its therapeutic potential in neurodegenerative disorders[J].Med Res Rev, 2020,40:633-653.
[22]Billesbølle CB, Azumaya CM, Kretsch RC, et al. Struc-ture of hepcidin-bound ferroportin reveals iron homeostatic mechanisms[J].Nature, 2020,586:807-811.
[23]Angelova PR, Esteras N, Abramov AY. Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: Finding ways for prevention[J].Med Res Rev, 2021,41:770-784.
[24]Deng H, Liu S, Pan D, et al. Myricetin reduces cytotoxicity by suppressing hepcidin expression in MES23.5 cells[J].Neural Regen Res,2021,16:1105-1110.

Research progress on STAT3 and pathogenesis of Parkinson's disease

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 11

Recommended Articles

Metrics

Comments

[1]	LIN Bai-bai, QIAN Feng-hua, QIAN Yi-ming, ZHAO Lei, SUN Qi, CHU Meng-yao, SHEN Meng-wen. Research progress of sepsis complicated with capillary leakage syndrome [J]. Basic & Clinical Medicine, 2022, 42(7): 1144-1147.
[2]	ZHAO Xiao-ling, HE Run-zhi, SUN Yu-jiao, ZHANG Xiao-chong, YANG Lin-fang, WANG Rui, CHENG Fang. Serum IFN-γ is increased in patients with active vitiligo [J]. Basic & Clinical Medicine, 2022, 42(7): 1067-1070.
[3]	WANG Hang-hang, WANG Dao-xin. Research advances in NETs and acute respiratory distress syndrome [J]. Basic & Clinical Medicine, 2021, 41(7): 1047-1051.
[4]	CHEN Yun-kun, LIU Huang, ZHANG Wen-bin, WANG Jie. Analysis of Traditional Chinese Medicine syndrome types in 52 COVID-19 patients with positive nucleic acid retest after discharge [J]. Basic & Clinical Medicine, 2021, 41(4): 558-561.
[5]	LAN Fei, LIU Tai-yang, YANG Jie. Advances in the role of intestinal ion channels in the pathogenesis of irritable bowel syndrome [J]. Basic & Clinical Medicine, 2020, 40(8): 1135-1139.
[6]	Wei LUO Gu Haiying. An overview of mechanism research on Helicobacter pylori pathogenic factors [J]. Basic & Clinical Medicine, 2018, 38(5): 713-716.
[7]	. Progress in the mechanism study on colitis associated cancer [J]. Basic & Clinical Medicine, 2018, 38(4): 568-572.
[8]	. Anaplastic lymphoma kinase and neuroblastoma [J]. Basic & Clinical Medicine, 2018, 38(12): 1791-1794.
[9]	. Progress in the research of acquired heterotopic ossification [J]. Basic & Clinical Medicine, 2017, 37(11): 1634-1639.
[10]	. PI3K/Akt signal pathway in pathogenesis of polycystic ovary syndrome [J]. Basic & Clinical Medicine, 2016, 36(11): 1596-1602.
[11]	Jing-jing WU; Biao CHEN. Microglia-derived IL-1 exacerbating the progress of Parkisinson's disease [J]. Basic & Clinical Medicine, 2010, 30(10): 1100-1104.